Health Catalyst to Announce First Quarter 2024 Operating Results and Host Conference Call on Thursday, May 9, 2024

SALT LAKE CITY, March 11, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has repurchased shares of its common stock ("Common Stock") in an aggregate amount of approximately $5 million. These repurchased shares were acquired between March 3, 2025, and March 10, 2025, as part of Health Catalyst's existing share repurchase program approved by its board of directors on August 2, 2022, which authorized repurchases of up to $40 million o

SALT LAKE CITY, Feb. 27, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system serving Southeastern Massachusetts. Signature Healthcare is collaborating with Health Catalyst to integrate data resource queries and unlock referral-related data powered by Health Catalyst Ignite™, a modern data and analytics ecosystem. Ignite integrates best-in-class cross

SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. "For the full year 2024, I am pleased to share that we achieved strong performance across our business, including total revenue of $307 million and Adjusted EBITDA of $26 million. Additionally, I am encouraged with our Technology segment, which had revenue of $195 million for full-year 2024 and $52 million for the fourth quarter of 2024, which represents 10% growth year-over-year. I am pleased with this pr

KeyBanc Capital Markets upgraded Health Catalyst from Sector Weight to Overweight and set a new price target of $9.00

KeyBanc Capital Markets downgraded Health Catalyst from Overweight to Sector Weight

Barclays initiated coverage of Health Catalyst with a rating of Overweight and set a new price target of $14.00

4 - Health Catalyst, Inc. (0001636422) (Issuer)

4 - Health Catalyst, Inc. (0001636422) (Issuer)

4 - Health Catalyst, Inc. (0001636422) (Issuer)

4 - Health Catalyst, Inc. (0001636422) (Issuer)

S-8 - Health Catalyst, Inc. (0001636422) (Filer)

10-K - Health Catalyst, Inc. (0001636422) (Filer)

8-K - Health Catalyst, Inc. (0001636422) (Filer)

Strengthens Executive Team with Seasoned Healthcare Finance Leader Modern Health, a leading global workplace mental health platform, today announces the appointment of Adam Brown as Chief Financial Officer. With an extensive background in healthcare finance and operations, including significant experience scaling high-growth healthcare technology companies, Brown brings deep industry expertise to the company. "Adam is a valued addition to Modern Health's leadership team, and we are thrilled to welcome him on board. His impressive track record and deep understanding of both public and private markets strengthens our executive bench as we continue to execute our vision," said Gyre Renwick

SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.Upfront provides a market-leading patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Upfront's automated patient acquisition and retention solu

SALT LAKE CITY, Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jill Hoggard Green, RN, BSN, MS, PhD, FAAN, former Chief Executive Officer of The Queen's Health Systems, has been appointed to serve as a member of Health Catalyst's board of directors ("Board") and a member of its Compensation Committee, effective December 1, 2024. "Jill has been an extraordinary leader throughout her career. With an impressive tenure in hea

SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024. "For the full year 2024, I am pleased to share that we achieved strong performance across our business, including total revenue of $307 million and Adjusted EBITDA of $26 million. Additionally, I am encouraged with our Technology segment, which had revenue of $195 million for full-year 2024 and $52 million for the fourth quarter of 2024, which represents 10% growth year-over-year. I am pleased with this pr

SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2024 operating results on Wednesday, February 26, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ424." A live audio webcast will be available online at https://ir.hea

SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2024. "For the third quarter of 2024, I am pleased with our strong financial results, including total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, with these results exceeding the mid-point of our quarterly guidance on each metric. This financial performance continues to demonstrate our ability to scale as we remain focused on driving profitable growth. We are encouraged with our bookings results through Q3

SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)